News: Research
Curbing COVID-19 Hospitalizations Requires Attention to Construction Workers
A new study shows how much more likely construction workers are to get diagnosed with COVID-19 compared to non-construction workers
Some Bacteria Sacrifice Themselves to Protect their Brethren from Antibiotics
Discovery may aid the fight against antibiotic resistance.
Discovery about Hep C Drug Offers Insights for Coronavirus Treatments
Finding offers important clues to developing drugs to stop other RNA viruses, such as SARS-COV-2.
How Chromosomes Organize and Genes Interact Needs Rethinking, Study Finds
Bacterial DNA much more twisted than originally thought.
Fighting Hepatitis C Virus, Using Clues from What Killed Bevo XIV
And other adventures in animal viruses teaching us about human disease
Promise of New Antibiotics Lies with Shackling Tiny Toxic Tetherballs to Bacteria
Bryan Davies of The University of Texas at Austin and a team have developed a system to identify new options for fighting bacteria.
Ancient Enzyme Could Boost Power of Liquid Biopsies to Detect and Profile Cancers
A set of medical tests called liquid biopsies could rapidly detect the presence of cancers, infectious diseases and other conditions from only a small blood sample.
Cracking the Code: Why Flu Pandemics Come At the End of Flu Season
Graduate student Spencer Fox and his colleagues found strong evidence that the late timing of flu pandemics is caused by two opposing factors.
Drug Engineered at UT Austin to Treat Anthrax Gains FDA Approval
The anthrax antitoxin obiltoxaximab received approval March 21 from the U.S. Food and Drug Administration (FDA).
